Who owns DERMATA THERAPEUTICS INC?
- Ticker: DRMA
- CUSIP Number: 249845504
Tip: Access positions for across all investors
Analyze quarterly positions in Dermata Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Dermata Therapeutics stock
Who bought or sold DERMATA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 20k | $22k | -1% | Sep 2026 |
|
| Welch & Forbes | 20k | $22k | 0% | Sep 2026 |
|
| State Street Corporation | 19k | $24k | 100% | Jun 2026 |
|
| UBS Group | 17k | $22k | -53% | Jun 2026 |
|
| Susquehanna International | 16k | $21k | 100% | Jun 2026 |
|
| XTX Topco | 15k | $19k | 100% | Jun 2026 |
|
| Advisory Alpha | 10k | $13k | 100% | Jun 2026 |
|
| Citigroup | 6.6k | $7.3k | 662400% | Sep 2026 |
|
| Tower Research Capital | 3.9k | $5.0k | 439% | Jun 2026 |
|
| SBI Securities | 102.00 | $111.996000 | 1% | Sep 2026 |
|
| Highline Wealth Partners | 26.00 | $29.000400 | 0% | Sep 2026 |
|
Who sold out of Dermata Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| MCF Advisors | Jun 2026 | 1.7k | $2.2k |
| Barclays | Jun 2026 | 270.00 | $348.003000 |